Skip to content
← Holders

Sphera Funds Management Ltd.

What Sphera Funds Management Ltd. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1496201 · Filed Nov 16, 2026

Positions
113
Reported value
$707.5M
Opened
32
Closed
24
Other managers included
2

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$474.1M
    114 positions
  2. Dec 31, 2025$517.3M
    99 positions
  3. Mar 31, 2026$629.7M
    96 positions
  4. Jun 30, 2026$766.5M
    105 positions
  5. Sep 30, 2026$707.5M
    113 positions
SecuritySharesChangeValueOf portfolio
MLYSMineralys Therapeutics, Inc.
1.3M−10.1%$33.2M4.7%
TEVATeva Pharmaceutical Industries Ltd
821.3KNew$32.5M4.6%
ALNYAlnylam Pharmaceuticals, Inc.
120.6K+1,016.7%$29.8M4.2%
CYTKCytokinetics Inc
361.9K+64.5%$23.9M3.4%
ISHARES TRISHARES SEMICDTR
37KNew$21M3%
BBIOBridgeBio Pharma, Inc.
311.7K+27.1%$20.5M2.9%
TSEMTower Semiconductor Ltd
84.7K−21.7%$19.3M2.7%
SNDXSyndax Pharmaceuticals Inc
1M−0.7%$18.9M2.7%
BMRNBioMarin Pharmaceutical Inc
293.2K−10.7%$17.6M2.5%
BIIBBiogen Inc.
75.8K−21.6%$17.1M2.4%
COGTCogent Biosciences, Inc.
501.5K+9.2%$16.1M2.3%
NVMINova Ltd.
39K+55.1%$15M2.1%
MDGLMadrigal Pharmaceuticals, Inc.
25.8K+48.1%$13M1.8%
SPDR SERIES TRUSTST STR SP BIOTPut option
75K−50.0%$11.8M1.7%
METAMeta Platforms, Inc.
16.2KNew$11.7M1.7%
IMTXImmatics N.V.
1.3M+81.2%$11.5M1.6%
SNYSanofi
269.5K±0%$11.1M1.6%
AZNAstraZeneca PLC
68.5K+9.6%$11.1M1.6%
ARK ETF TRGENOMIC REV ETFPut option
200KNew$10.8M1.5%
MAZEMaze Therapeutics, Inc.
366.3K−12.3%$10M1.4%
LLYEli Lilly & Co
8K±0%$9.3M1.3%
KLACKLA Corp
45.2KNew$8.8M1.2%
LRCXLAM Research Corp
25.9K+40.2%$8.5M1.2%
PFEPfizer Inc
286K±0%$8.2M1.2%
IDYAIDEAYA Biosciences, Inc.
211.4K+7.6%$8.1M1.1%
RYTMRhythm Pharmaceuticals, Inc.
80.4K±0%$7.7M1.1%
JNJJohnson & Johnson
28.8K±0%$7.6M1.1%
TNGXTango Therapeutics, Inc.
304.3K+19.7%$7.6M1.1%
IRONDisc Medicine, Inc.
114.7K+80.6%$7.5M1.1%
VORVor Biopharma Inc.
383.4K−7.9%$7.3M1%
AMATApplied Materials Inc
14.3K+29.5%$7.3M1%
ABVXAbivax S.A.
73.7KNew$7.3M1%
PHVSPharvaris N.V.
229.7KNew$7.3M1%
CAMTCamtek Ltd
46.8KNew$7.3M1%
MRKMerck & Co., Inc.
48.6K−17.1%$7.1M1%
NVCTNuvectis Pharma, Inc.
323.4K−15.5%$6.8M1%
NVSNovartis AG
45K−10.0%$6.4M0.9%
ABBVAbbVie Inc.
22.3K−26.4%$5.8M0.8%
TRAXFirst Tracks Biotherapeutics, Inc.
160.2K+474.8%$5.7M0.8%
TRVITrevi Therapeutics, Inc.
385.3K−22.8%$5.5M0.8%
MSLESatellos Bioscience Inc.
638.7K−2.1%$5.4M0.8%
ANNXAnnexon, Inc.
1.2MNew$5.2M0.7%
RAREUltragenyx Pharmaceutical Inc.
338.6K−42.5%$5.1M0.7%
CLYMClimb Bio, Inc.
416.7K−13.9%$4.8M0.7%
HELPHelus Pharma Inc.
388.2K−76.1%$4.8M0.7%
ORICOric Pharmaceuticals, Inc.
349.4K−53.6%$4.7M0.7%
RVMDRevolution Medicines, Inc.
22.4K±0%$4.6M0.6%
NVONovo Nordisk a S
120.7K±0%$4.6M0.6%
ELVNEnliven Therapeutics, Inc.
99.8K−11.5%$4.6M0.6%
TENXTenax Therapeutics, Inc.
2.3M+1,826.5%$4.4M0.6%
TECXTectonic Therapeutic, Inc.
187.4KNew$4.4M0.6%
GSKGSK PLC
90K−11.8%$4.3M0.6%
RLAYRelay Therapeutics, Inc.
233.8K±0%$4.2M0.6%
SVRASavara Inc
802.6K+6.1%$4.1M0.6%
CBIOCrescent Biopharma, Inc.
279.7KNew$4.1M0.6%
ACADAcadia Pharmaceuticals Inc
202.1K−43.3%$4.1M0.6%
OVIDOvid Therapeutics Inc.
1.6M+18.3%$4M0.6%
ANLAdlai Nortye Group Ltd.
235.7KNew$3.8M0.5%
MDWDMediWound Ltd.
273.2K±0%$3.8M0.5%
HRMYHarmony Biosciences Holdings, Inc.
95.8K−45.8%$3.8M0.5%
ACOGAlpha Cognition Inc.
415.6K−23.9%$3.7M0.5%
QTTBQ32 Bio Inc.
448.9KNew$3.7M0.5%
IMMXImmix Biopharma, Inc.
355.8K+31.8%$3.7M0.5%
HELPHelus Pharma Inc.Call option
300KNew$3.7M0.5%
PRAXPraxis Precision Medicines, Inc.Call option
12.5K±0%$3.6M0.5%
AVTXAvalo Therapeutics, Inc.
235K+1.2%$3.6M0.5%
DYNDyne Therapeutics, Inc.
222.6K+11.5%$3.6M0.5%
TRVITrevi Therapeutics, Inc.Call option
250KNew$3.6M0.5%
ELDNEledon Pharmaceuticals, Inc.
1.4M+16.9%$3.5M0.5%
SRRKScholar Rock Holding Corp
72.3K−23.3%$3.5M0.5%
CRVSCorvus Pharmaceuticals, Inc.
298.2K+21.7%$3.4M0.5%
RAPPRapport Therapeutics, Inc.Put option
100KNew$3.4M0.5%
RAPPRapport Therapeutics, Inc.
100KNew$3.4M0.5%
PALIPalisade Bio, Inc.
2.5M+9.2%$3.3M0.5%
LRMRLarimar Therapeutics, Inc.
1M+11.8%$3.3M0.5%
PRLDPrelude Therapeutics Inc
844.8K−17.2%$3.3M0.5%
CLDXCelldex Therapeutics, Inc.Put option
100KNew$3.2M0.5%
EVMNEvommune, Inc.
390.6K+1,626.0%$3.2M0.5%
LTGOLatigo Biotherapeutics, Inc.
192.1KNew$3.2M0.5%
AAOIApplied Optoelectronics, Inc.
32.2KNew$3.2M0.5%
CTNMContineum Therapeutics, Inc.
221.4K+20.7%$3M0.4%
CLDXCelldex Therapeutics, Inc.
91.1K−62.2%$3M0.4%
PRQRProQR Therapeutics N.V.
1.8M±0%$2.9M0.4%
KURAKura Oncology, Inc.
267.5K−9.3%$2.9M0.4%
WVEWave Life Sciences, Inc.
747.3K+17.1%$2.8M0.4%
PMNProMIS Neurosciences Inc.
254.8K−21.7%$2.8M0.4%
AMGNAmgen Inc
6K−20.0%$2.5M0.4%
CABACabaletta Bio, Inc.
1.3M−4.9%$2.4M0.3%
TECXTectonic Therapeutic, Inc.Call option
100KNew$2.3M0.3%
BBOTBridgeBio Oncology Therapeutics, Inc.
464.5K+0.8%$1.9M0.3%
SNDXSyndax Pharmaceuticals IncCall option
100KNew$1.9M0.3%
UPBUpstream Bio, Inc.
325.8K+48.3%$1.7M0.2%
PYXSPyxis Oncology, Inc.
689KNew$1.6M0.2%
ERASErasca, Inc.
109.2KNew$1.6M0.2%
JBIOJade Biosciences, Inc.
105.5KNew$1.5M0.2%
IKTInhibikase Therapeutics, Inc.
688.3K+6.0%$1.4M0.2%
BIOABioAge Labs, Inc.
182.6K−14.6%$1.3M0.2%
TSHATaysha Gene Therapies, Inc.
250K±0%$1.2M0.2%
NTLAIntellia Therapeutics, Inc.
90.3KNew$1.1M0.2%
QNRXQuoin Pharmaceuticals Ltd.
236.2KNew$1.1M0.2%
ANNXAnnexon, Inc.Put option
250KNew$1.1M0.1%
ANNXAnnexon, Inc.Call option
250KNew$1.1M0.1%
SRZNSurrozen, Inc.
18.8KNew$605.7K0.1%
HOWLWerewolf Therapeutics, Inc.
626.8K±0%$578.1K0.1%
VYGRVoyager Therapeutics, Inc.
214.6K−49.8%$575K0.1%
ORGOOrganogenesis Holdings Inc.
330K−40.0%$452.1K0.1%
CTMXCytomX Therapeutics, Inc.
125.4K−85.7%$341.1K0.1%
IRONDisc Medicine, Inc.Call option
50KNew$334.5K0.1%
TENXTenax Therapeutics, Inc.Call option
127.6K±0%$241.2K0.1%
TRAWTraws Pharma, Inc.
398.5K±0%$236.6K0.1%
APREAprea Therapeutics, Inc.
270K±0%$202.5K0.1%
SKYESkye Bioscience, Inc.
87.3K−87.1%$140.5K0.1%
CRISCuris Inc
39.7KNew$33.3K0.1%